USPTO serial 90707193
GENOMICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 15, 2023
- Examiner
- SNYDER, NELSON B
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GENOMICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William C. Wright
William C. Wright EPSTEIN DRANGEL LLP60 EAST 42ND STREET, SUITE 2520NEW YORK, NY 10165UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software and mobile applications for collecting, analyzing, monitoring, reporting, recording, storing, manipulating, organizing and tracking data and information in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; downloadable software for applications development; downloadable computer software for collecting, analyzing, monitoring, reporting, recording, storing, manipulating, organizing and tracking data and information in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; downloadable computer software for use as an application programming interface (API) in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; downloadable computer software to enable transmission, access, organization, and management of data and information in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics, all for use on any computing device including mobile devices, handheld devices, tablets and wearable computer peripherals; downloadable computer application software for collecting, analyzing, monitoring, reporting, recording, storing, manipulating, organizing and tracking data and information, all for use on any computing device including mobile devices, handheld devices, tablets and wearable computer peripherals in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; downloadable computer software applications to enable transmission, access, organization, and management of data and information in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics, all for use with any computing device including mobile devices, handheld devices, tablets and wearable computer peripherals, all in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; downloadable software application for downloading, uploading and accessing multimedia content, text, and other data on a computer or other portable consumer electronic device including mobile devices, handheld devices, tablets and wearable computer peripherals, all in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; downloadable computer databases in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; downloadable electronic publications, namely, magazines and newsletters, all in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics | ACTIVE | — |
| 035 | Business consultancy in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; business development services in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; business research in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; analysis and evaluation of business and commercial data in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; business administration of consumer loyalty programs involving discounts or incentives in the nature of online loyalty points and discount codes for use with third party retailers when program members achieve certain health goals; retail store services featuring downloadable computer software, data and reports, all in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; compilation of information into computer databases; management and compilation of computer databases containing data relating to health, medicine, pharmaceutical development, genetics and bioinformatics; data processing services in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; statistical analysis and reporting for business purposes, all in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; consultancy, advisory and information services for all the aforementioned services | ACTIVE | — |
| 036 | Financial risk assessment services; financial risk assessment services relating to health; financial risk assessment services relating to medical care; financial risk assessment services relating to dental care; financial advice; investment management services; actuarial services; insurance administration; health insurance administration; medical insurance administration; dental insurance administration; life insurance administration; consultancy, advisory and information services for all the aforementioned services | ACTIVE | — |
| 042 | Electronic storage of data relating to the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; software as a service (SaaS) services featuring software for collecting, analyzing, monitoring, reporting, recording, storing, manipulating, organizing and tracking data and information, to enable transmission, access, organization, and management of data and information, all in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; platform as a service (PaaS) featuring computer software platforms for use in database management; infrastructure as a service (IaaS) services, namely, hosting software for collecting, analyzing, monitoring, reporting, recording, storing, manipulating, organizing and tracking data and information, to enable transmission, access, organization, and management of data and information, all in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; computer project management services; computer programming; installation of computer software and computer programs; computer software application development; maintenance and updating of computer software; maintenance of online databases for others; scientific research conducted using databases; data mining services; providing online non-downloadable software applications via a web-browser for health monitoring and risk assessment in diseases, accessible by any computing device including mobile devices, handheld devices, tablets and wearable computer peripherals; provision online of non-downloadable software for use in data management, data storage, data analysis and report generation in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; industrial research and laboratory analysis services in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; DNA analysis services for scientific research purposes, and providing informational reports related thereto in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; quality management services, namely, quality analysis and evaluation of data in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; development and testing of computer algorithms and software in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics; providing medical and scientific research information and advice relating to health, medicine, pharmaceutical development, genetics and bioinformatics; provision of information in the field of pharmaceutical drug development; provision of scientific research information in the fields of genetics and bioinformatics; consultancy, advisory and information services for all the aforementioned services | ACTIVE | — |
| 044 | Medical health care services; medical diagnostic testing, monitoring and reporting services; medical screening; medical testing services relating to the diagnosis and treatment of diseases; medical services, namely, analysis of data in the fields of health, medicine, pharmaceutical development, genetics and bioinformatics, all for medical diagnostic or treatment purposes; provision of information relating to health and medicine; healthcare services; health screening services in the field of cancers, cardiovascular disease, autoimmune disorders, and diabetes; health counselling; genetics counselling; consultancy, advisory and information services for all the aforementioned services; all of the foregoing services being provided by primary, secondary, and tertiary care professional | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Genomics PLC
- Other trademarks owned by Genomics PLC
- Other trademarks owned by Genomics PLC
- Other trademarks owned by GENOMICS LIMITED
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GENOMICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 12, 2025 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 15, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 15, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 30, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 30, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 10, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 26, 2023 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 24, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 24, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 24, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 24, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 24, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 24, 2023 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 14, 2023 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 30, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 30, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 30, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 28, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 28, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 28, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 26, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 25, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 25, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 17, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 17, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 17, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 24, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 24, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 23, 2022 | ALIE | ASSIGNED TO LIE | — |
| Jul 28, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 29, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 19, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 13, 2021 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 12, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 15, 2021 | NWAP | NEW APPLICATION ENTERED | — |